Chargement en cours...
In silico improvement of β(3)-peptide inhibitors of p53•hDM2 and p53•hDMX
There is great interest in molecules capable of inhibiting the interactions between p53 and its negative regulators hDM2 and hDMX, as these molecules have validated potential against cancers in which one or both oncoproteins are overexpressed. We reported previously that appropriately substituted β(...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2754742/ https://ncbi.nlm.nih.gov/pubmed/19415930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ja901478e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|